Correction to “Prognostic value of preoperative fibrinogen, neutrophil-to-lymphocyte ratio, serum alpha-fetoprotein, and prealbumin for patients with primary liver cancer undergoing transarterial chemoembolization”
Abstract
Correction to “Liu QQ, Li YD, Chen JX, Zhang LL, Guan RC, Zhao W, Meng LY. Prognostic value of preoperative fibrinogen, neutrophil-to-lymphocyte ratio, serum alpha-fetoprotein, and prealbumin for patients with primary liver cancer undergoing transarterial chemoembolization. World J Gastrointest Oncol 2025; 17(6): 103198 PMID: 40547171 DOI: 10.4251/wjgo.v17.i6.103198”. The funding number listed in the "Supported by" section of this article needs to be corrected.
Fields of Study & Subjects
Inflammatory Biomarkers in Disease Prognosis
Hepatocellular Carcinoma Treatment and Prognosis
Venous Thromboembolism Diagnosis and Management
Publication details
- Journal / source
- World Journal of Gastrointestinal Oncology
- Volume
- 18
- Issue
- 1
- Pages
- 116230–116230
- Publication date
- 9 January 2026
- Language
- EN